Your session is about to expire
← Back to Search
Cryoballoon Ablation for Persistent Atrial Fibrillation (PIVoTAL-IDE Trial)
PIVoTAL-IDE Trial Summary
This trial will compare the recurrence of atrial fibrillation at 12 months after ablation in patients who receive PVI + PWI to those who receive PVI alone.
PIVoTAL-IDE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPIVoTAL-IDE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PIVoTAL-IDE Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a history of thickened heart muscles.I have had a continuous episode of AFib lasting more than 7 days.I am over 18 and having my first catheter ablation for AF; I may have had a previous ablation for a different heart rhythm issue.I have not had a stroke, heart attack, or severe chest pain in the last 2 months.I have AFib symptoms that didn't improve with at least one heart rhythm medication.You must have had a documented episode of atrial fibrillation lasting more than 7 days in the year before the procedure.I have severe heart failure.I am able to understand and consent to the trial.My heart's pumping ability is significantly reduced.I have a heart condition I was born with, whether treated or not.You are pregnant or had a positive pregnancy test within the past week.My atrial fibrillation is caused by a treatable condition.I have had atrial fibrillation for a long time.Your left atrial diameter is larger than 55 millimeters when measured from a specific view during an echocardiogram.I have a blood clot in the left side of my heart.I have had a procedure to correct heart rhythm problems on the left side of my heart.You are not expected to live for more than a year.
- Group 1: Cryoballoon PVI + Posterior Wall Isolation
- Group 2: Standard Cryoballoon Pulmonary Vein Isolation (PVI)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals are being admitted to this scientific experiment?
"Affirmative. The data hosted on clinicaltrials.gov indicates that this medical research is currently seeking participants, with the initial post dating to April 30th 2021 and the most recent edit occurring September 26th 2022. To date, 366 patients have been recruited from 15 sites."
How many clinical sites have been designated to conduct this trial?
"This medical trial is recruiting in 15 cities, including Stanford University Medical Center (Stanford), Staten Island University Hospital(Staten Island) and the University of California, Davis Medical Centre (Sacramento). The other 12 sites can be found on clinicialtrials.gov."
Are physicians currently enlisting participants for this research?
"According to the data found on clinicaltrials.gov, this medical trial is actively recruiting for participants as of October 2020. The initial post was made in April 2021 and the last update happened in September 2022."
Share this study with friends
Copy Link
Messenger